Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Breakdown
Segments
Innovative MedicineView metric
MEDTECHView metric
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Innovative Medicine | $5.46B | $4.48B | $4.01B | $5.21B | $5.55B | $6.45B | $5.06B | $5.32B |
| MEDTECH | $1.09B | $1.06B | $72.00M | $1.42B | $1.20B | $1.29B | $201.00M | $1.24B |
| Total | $5.75B | $3.34B | $3.89B | $13.63B | $6.49B | $7.49B | $4.97B | $5.99B |